• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对氧磷酶的Gln-Arg192多态性与2型糖尿病患者的冠心病

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.

作者信息

Ruiz J, Blanché H, James R W, Garin M C, Vaisse C, Charpentier G, Cohen N, Morabia A, Passa P, Froguel P

机构信息

Division d'Epidémiologie Clinique, Geneva University Hospital, Switzerland.

出版信息

Lancet. 1995 Sep 30;346(8979):869-72. doi: 10.1016/s0140-6736(95)92709-3.

DOI:10.1016/s0140-6736(95)92709-3
PMID:7564671
Abstract

Paraoxonase is a high-density-lipoprotein-associated enzyme capable of hydrolysing lipid peroxides. Thus it might protect lipoproteins from oxidation. It has two isoforms, which arise from a glutamine (A isoform) to arginine (B isoform) interchange at position 192. The relevance of this polymorphism to coronary heart disease (CHD) in non-insulin-dependent diabetic patients was investigated in case-control study. Of the 434 patients, 171 had confirmed coronary artery disease; the other 263 had no history of such disease. The B allele and AB+BB genotypes were associated with an increased risk of coronary heart disease. Compared with subjects homozygous for the A allele (AA genotype), the odds ratio of CHD for subjects homozygous for the B allele was 2.5 (95% CI 1.2-5.3) and that for those heterozygous for the B allele was 1.6 (95% CI 1.1-2.4), suggesting a codominant effect on cardiovascular risk. When subjected to multivariate analysis, the B allele remained significantly associated with CHD (odds ratio 1.94, p = 0.03). The paraoxonase gene polymorphism is thus an independent cardiovascular risk factor in non-insulin-dependent diabetic patients. A possible explanation for this finding is that activity of the paraoxonase B isotype does not protect well against lipid oxidation, a major atherogenic pathway.

摘要

对氧磷酶是一种与高密度脂蛋白相关的酶,能够水解脂质过氧化物。因此,它可能保护脂蛋白免于氧化。它有两种同工型,由192位的谷氨酰胺(A同工型)与精氨酸(B同工型)互换产生。在一项病例对照研究中,调查了这种多态性与非胰岛素依赖型糖尿病患者冠心病(CHD)的相关性。在434名患者中,171人确诊患有冠状动脉疾病;另外263人无此类疾病史。B等位基因以及AB + BB基因型与冠心病风险增加相关。与A等位基因纯合子(AA基因型)的受试者相比,B等位基因纯合子受试者患冠心病的比值比为2.5(95%置信区间1.2 - 5.3),B等位基因杂合子受试者的比值比为1.6(95%置信区间1.1 - 2.4),提示对心血管风险有共显性效应。进行多变量分析时,B等位基因仍与冠心病显著相关(比值比1.94,p = 0.03)。因此,对氧磷酶基因多态性是非胰岛素依赖型糖尿病患者独立的心血管危险因素。对这一发现的一种可能解释是,对氧磷酶B同种型的活性不能很好地抵御脂质氧化,而脂质氧化是主要的致动脉粥样硬化途径。

相似文献

1
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.对氧磷酶的Gln-Arg192多态性与2型糖尿病患者的冠心病
Lancet. 1995 Sep 30;346(8979):869-72. doi: 10.1016/s0140-6736(95)92709-3.
2
Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.对氧磷酶192 Gln/Arg基因多态性、2型糖尿病中的冠状动脉疾病和心肌梗死
Diabetes. 1999 Mar;48(3):623-7. doi: 10.2337/diabetes.48.3.623.
3
Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus.
J Clin Endocrinol Metab. 1997 Jul;82(7):2257-60. doi: 10.1210/jcem.82.7.4096.
4
The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.人类对氧磷酶基因的谷氨酰胺-精氨酸192多态性与意大利患者的冠状动脉疾病无关。
Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1611-6. doi: 10.1161/01.atv.18.10.1611.
5
Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.对氧磷酶1 192 Gln/Arg基因多态性与脑血管疾病:与2型糖尿病的相互作用
Exp Clin Endocrinol Diabetes. 2001;109(3):141-5. doi: 10.1055/s-2001-14836.
6
Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease.
Int J Cardiol. 1996 Nov 15;57(1):69-73. doi: 10.1016/s0167-5273(96)02779-9.
7
The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.人类对氧磷酶基因的Gln-Arg 191多态性与台湾地区中国人患冠状动脉疾病的风险无关。
Atherosclerosis. 1998 Dec;141(2):259-64. doi: 10.1016/s0021-9150(98)00179-8.
8
Genetic polymorphism of paraoxonase and the risk of coronary heart disease.对氧磷酶的基因多态性与冠心病风险
Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1067-73. doi: 10.1161/01.atv.17.6.1067.
9
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.血清对氧磷酶(PON1)55和192多态性以及非胰岛素依赖型糖尿病患者的对氧磷酶活性和浓度
Atherosclerosis. 1998 Aug;139(2):341-9. doi: 10.1016/s0021-9150(98)00095-1.
10
Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?
Eur J Endocrinol. 2001 Jun;144(6):639-44. doi: 10.1530/eje.0.1440639.

引用本文的文献

1
Paraoxonase-1 as a Cardiovascular Biomarker in Caribbean Hispanic Patients Treated with Clopidogrel: Abundance and Functionality.对接受氯吡格雷治疗的加勒比西班牙裔患者的心血管生物标志物——对氧磷酶 1:丰度和功能。
Int J Mol Sci. 2024 Oct 3;25(19):10657. doi: 10.3390/ijms251910657.
2
The importance of paraoxonase 1 activity in chronic kidney disease.对慢性肾脏病患者血清对氧磷酶 1 活性的重视。
Ren Fail. 2024 Dec;46(2):2376930. doi: 10.1080/0886022X.2024.2376930. Epub 2024 Jul 10.
3
Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis.
对氧磷酶 1:酶的进化及其在预防动脉粥样硬化中的作用。
Curr Opin Lipidol. 2024 Aug 1;35(4):171-178. doi: 10.1097/MOL.0000000000000936. Epub 2024 Jun 18.
4
Paraoxonase 1 and atherosclerosis.对氧磷酶1与动脉粥样硬化
Front Cardiovasc Med. 2023 Feb 16;10:1065967. doi: 10.3389/fcvm.2023.1065967. eCollection 2023.
5
The Hydrolysis Rate of Paraoxonase-1 Q and R Isoenzymes: An In Silico Study Based on In Vitro Data.对氧磷酶 1 Q 和 R 同工酶的水解速度:基于体外数据的计算机模拟研究。
Molecules. 2022 Oct 11;27(20):6780. doi: 10.3390/molecules27206780.
6
Paraoxonase 1 gene variants concerning cardiovascular mortality in conventional cigarette smokers and non-smokers treated with hemodialysis.对常规吸烟和非吸烟血液透析患者心血管死亡率的对氧磷酶 1 基因变异的研究。
Sci Rep. 2021 Sep 30;11(1):19467. doi: 10.1038/s41598-021-98923-8.
7
Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.对血脂异常、心血管疾病和血液透析患者死亡率的研究表明,对氧磷酶 1 与这些问题存在关联。
Sci Rep. 2021 Mar 24;11(1):6773. doi: 10.1038/s41598-021-86231-0.
8
Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.2型糖尿病与心血管疾病:遗传和表观遗传联系
Front Endocrinol (Lausanne). 2018 Jan 17;9:2. doi: 10.3389/fendo.2018.00002. eCollection 2018.
9
Molecular Dynamics Approach in the Comparison of Wild-Type and Mutant Paraoxonase-1 Apoenzyme Form.野生型和突变型对氧磷酶-1脱辅基酶形式比较中的分子动力学方法
Bioinform Biol Insights. 2015 Sep 13;9:129-40. doi: 10.4137/BBI.S25626. eCollection 2015.
10
Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.北非人群中对氧磷酶1(PON1)基因多态性与急性冠脉综合征风险的关联
PLoS One. 2015 Aug 4;10(8):e0133719. doi: 10.1371/journal.pone.0133719. eCollection 2015.